Valuation: Granules India Limited

Market Cap 222B 2.32B 2.04B 1.89B 1.74B 3.29B 3.35B 22.5B 8.82B 109B 8.73B 8.53B 377B P/E 2026
25.4x
P/E 2027 * 29.2x
Enterprise Value 225B 2.35B 2.06B 1.91B 1.76B 3.32B 3.39B 22.76B 8.93B 111B 8.83B 8.64B 382B EV / Sales 2026
2.94x
EV / Sales 2027 * 3.61x
Free-Float
60.69%
Yield 2026 *
0.16%
Yield 2027 * 0.16%
1 day+0.89%
1 week+5.04%
Current month+10.39%
1 month+17.15%
3 months+41.84%
6 months+51.82%
Current year+49.95%
1 week 850.55
Extreme 850.55
907
1 month 736.8
Extreme 736.8
907
Current year 520.05
Extreme 520.05
907
1 year 433
Extreme 433
907
3 years 287.55
Extreme 287.55
907
5 years 227
Extreme 227
907
10 years 71.75
Extreme 71.75
907
Manager TitleAgeSince
Chief Executive Officer 71 30/07/2025
President - 13/10/2024
President - 31/08/2023
Director TitleAgeSince
Chairman 71 20/08/2013
Director/Board Member 42 31/12/2004
Director/Board Member 66 30/05/2012
Change 5-day change 1-year change 3-year change Capi.($)
+0.89%+5.04%+91.41%+196.84% 2.31B
-0.56%-1.52%+49.04%+171.88% 1,060B
+0.31%-0.60%+64.29%+62.31% 619B
-0.03%-2.65%+28.86%+85.64% 438B
-1.75%-0.33%+28.78%+23.58% 333B
+0.24%-0.42%+29.46%+47.26% 282B
-1.75%-10.57%+20.67%+22.07% 267B
+0.67%+1.03%-26.10%-37.96% 218B
-0.81%-1.63%+22.07%+58.33% 196B
+1.21%+1.38%+19.85%+71.29% 161B
Average -0.12%-1.43%+32.83%+70.12% 357.62B
Weighted average by Cap. -0.28%-2.11%+36.31%+84.01%

Financials

2026 2027 *
Net sales 53.08B 555M 486M 451M 415M 784M 799M 5.37B 2.11B 26.07B 2.08B 2.04B 90.03B 62.13B 649M 569M 527M 485M 918M 936M 6.28B 2.46B 30.51B 2.44B 2.38B 105B
Net income 5.89B 61.58M 54.02M 50.03M 46.03M 87.07M 88.76M 596M 234M 2.89B 231M 226M 10B 7.76B 81.07M 71.1M 65.86M 60.59M 115M 117M 785M 308M 3.81B 304M 298M 13.16B
Net Debt 2.64B 27.6M 24.21M 22.42M 20.63M 39.03M 39.78M 267M 105M 1.3B 104M 101M 4.48B 1.87B 19.53M 17.13M 15.87M 14.6M 27.61M 28.15M 189M 74.17M 918M 73.35M 71.74M 3.17B
Logo Granules India Limited
Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceutical products segment. Its geographical segments include within India and outside India. The Company has a presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). It produces and supplies Paracetamol, Metformin, Guaifenesin, and Methocarbamol APIs. It has over 10 manufacturing facilities, approximately eight of which are located in India and two in the United States. The Company sells its products in global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific, and India. Its subsidiaries include Granules USA Inc and Granules Europe Limited. It also owns Senn Chemicals AG, a contract development and manufacturing organization (CDMO) specializing in peptide development and manufacturing.
Employees
4,066
Date Price Change Volume
13/07/26 ₹897.50 +0.89% 22,609
10/07/26 ₹889.55 +0.95% 25,939
09/07/26 ₹881.15 +2.71% 74,563
08/07/26 ₹857.90 -0.63% 149,169
07/07/26 ₹863.35 +1.05% 111,001
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
897.50INR
Average target price
802.29INR
Spread / Average Target
-10.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 532482 Stock